Results for tag: "Follicular Lymphoma Drug"

Follicular Lymphoma Drug market is a subset of the larger Lymphoma Drugs market. It is composed of drugs used to treat follicular lymphoma, a type of non-Hodgkin's lymphoma. These drugs are used to reduce the size of tumors, slow the growth of cancer cells, and reduce symptoms. Common drugs used to treat follicular lymphoma include rituximab, bendamustine, and lenalidomide. Other drugs, such as obinutuzumab, are also used in combination with chemotherapy. The Follicular Lymphoma Drug market is highly competitive, with many companies offering treatments for this type of cancer. Some of the major players in the market include Roche, Novartis, Merck, AbbVie, and Pfizer. Other companies, such as Celgene, Gilead, and Johnson & Johnson, also offer treatments for follicular lymphoma. Show Less Read more